user avatar
Elaine Chen
@elaineywchen
reporter @statnews, ✉️ [email protected] | signal: elaineywchen.70
Chicago, IL
Joined January 2018
Posts
  • Pinned
    user avatar
    Job update: Starting next week, I’ll be moving onto the biotech team at STAT. As a national biotech reporter, I’ll still be covering obesity, diabetes and heart drugs, but also many other drugs and the biopharma industry as a whole. Send ideas, tips to [email protected]
  • user avatar
    Some news: today is my first day @statnews! I'll be developing a new beat as their first cardiovascular reporter, covering all aspects of heart and metabolic conditions (including diabetes and obesity). SO excited to join a newsroom I've long admired
  • user avatar
    Some professional news: after interning in the fall @business, I’m joining as a full time reporter! Today’s my first day. So excited to be back in such an amazing newsroom
  • user avatar
    The entire intersection of Roosevelt and Delano Ct filled with red as @CTULocal1 members and supporters continue to rally
    00:00
  • user avatar
    I started a new internship with @business, today's my first day reporting on the finance team! I'll be covering banks and other financial services companies. Send ideas and tips to [email protected]
  • user avatar
    The @CTULocal1 rally is now in the intersection of Roosevelt and Delano, cars are parked in the middle of Roosevelt
    00:00
  • user avatar
    It’s been one year since I joined @statnews! Very grateful to be working in this newsroom with the most supportive colleagues
  • user avatar
    “I’ve been told many times I have all the talent and the whole package, but I’m just ‘not the right person.’” Though Asian American doctors are overrepresented in medicine, they're largely invisible in leadership. via @ushamcfarling
  • user avatar
    At virtual grad, one RD called out UChicago: “In Chicago’s dedication to ideas…it is easy to take for granted a hierarchy in which ideas are on top and the community is below existing only for the sake of ideas…but the pandemic has given a shock to this means/end hierarchy.”
  • user avatar
    NEW: A key female chemist has been edged out of the Ozempic origin story. Svetlana Mojsov's experiences expose a disciplinary bias against chemists in favor of MDs and show how narratives of scientific discovery get passed down. From me and @MeganMolteni
  • user avatar
    Novo is discontinuing an insulin after cutting its price, highlighting a key gap in policy efforts: Even if officials get pharma to lower prices, companies can choose to just pull the drug, without guaranteeing someone else continues to make the compound
  • user avatar
    NEW: Blockbuster obesity drugs are changing the narrative on what it means to be diseased, spurring one of the biggest pharma battles ever while raising questions of cost, equity and cultural bias. The first in a new @statnews series, w/ @matthewherper: statnews.com/2023/03/05/wei…
  • user avatar
    “Oceans are rising, so are we,” @climatestrikeil marchers shout louder and louder as their chants echo off the buildings, as they head west on Van Buren
    00:00
  • user avatar
    Novo is thinking about a "vaccine-like" version of Wegovy, a long-lasting obesity drug taken perhaps annually, the chief scientific officer told me in an interview.